{"log_id": 1591536476902737813, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 3e-05, "average": 0.99652, "min": 0.978774}, "location": {"width": 267, "top": 187, "height": 28, "left": 200}, "words": "核准日期:2007年04月20日"}, {"probability": {"variance": 3e-05, "average": 0.997694, "min": 0.976715}, "location": {"width": 268, "top": 217, "height": 28, "left": 199}, "words": "修改日期:2007年09月05日"}, {"probability": {"variance": 1e-05, "average": 0.99795, "min": 0.987437}, "location": {"width": 268, "top": 246, "height": 26, "left": 200}, "words": "修改日期:2007年10月10日"}, {"probability": {"variance": 0.009909, "average": 0.969253, "min": 0.5977}, "location": {"width": 265, "top": 276, "height": 25, "left": 201}, "words": "修改日期:2008年06月1日"}, {"probability": {"variance": 6.8e-05, "average": 0.996044, "min": 0.964926}, "location": {"width": 268, "top": 304, "height": 28, "left": 200}, "words": "修改日期:2013年02月27日"}, {"probability": {"variance": 3e-06, "average": 0.998603, "min": 0.994167}, "location": {"width": 285, "top": 370, "height": 33, "left": 508}, "words": "多西他赛注射液说明书"}, {"probability": {"variance": 0.001202, "average": 0.988603, "min": 0.850606}, "location": {"width": 338, "top": 420, "height": 31, "left": 481}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 0.001495, "average": 0.982773, "min": 0.82722}, "location": {"width": 513, "top": 483, "height": 29, "left": 220}, "words": "警告:中毒性死亡,肝毒性,中性粒细胞减少,超敏反应,体液潴留"}, {"probability": {"variance": 0.001619, "average": 0.984969, "min": 0.767479}, "location": {"width": 859, "top": 509, "height": 36, "left": 217}, "words": "1.在具有肝功能异常的患者,接受高剂量治疗的患者,以及既往使用过铂类为基础的化疗再接受多西他赛单药"}, {"probability": {"variance": 0.000443, "average": 0.991377, "min": 0.916982}, "location": {"width": 347, "top": 548, "height": 25, "left": 267}, "words": "m治疗的患者中,治疗相关死亡的发生率增加"}, {"probability": {"variance": 0.007012, "average": 0.959162, "min": 0.587796}, "location": {"width": 863, "top": 572, "height": 37, "left": 216}, "words": "2.对于出现胆红素>正常值(ULN)上限的患者,或者AST和/或ALT>1.5xULN合并碱性磷酸酶>2.5xULN的患者,应"}, {"probability": {"variance": 0.00519, "average": 0.983542, "min": 0.501834}, "location": {"width": 854, "top": 604, "height": 34, "left": 222}, "words": "该避免使用多西他赛:存在胆红素升高或转氨酶异常伴碱性磷酸酶升高的患者发生4级的中性粒细胞减少,发热性中"}, {"probability": {"variance": 0.000192, "average": 0.992944, "min": 0.935767}, "location": {"width": 858, "top": 635, "height": 34, "left": 221}, "words": "性粒细胞减少,感染,严重的血小板减少,严重胃炎,严重皮肤毒性以及中毒性死亡的风险更高。仅存在转氨酶>1.5"}, {"probability": {"variance": 0.000259, "average": 0.991683, "min": 0.927649}, "location": {"width": 838, "top": 668, "height": 32, "left": 238}, "words": "ULN的患者4级的中性粒细胞减少发生率更高,但中毒性死亡的发生率不高。因此,在每个周期开始给予多西他赛"}, {"probability": {"variance": 0.000276, "average": 0.993898, "min": 0.915396}, "location": {"width": 392, "top": 704, "height": 29, "left": 222}, "words": "之前应进行胆红素、AST或ALT以及碱性磷酸酶检查"}, {"probability": {"variance": 0.001113, "average": 0.973377, "min": 0.909639}, "location": {"width": 176, "top": 741, "height": 21, "left": 221}, "words": "3.中性粒细胞计数<150"}, {"probability": {"variance": 0.008205, "average": 0.966252, "min": 0.593412}, "location": {"width": 587, "top": 732, "height": 29, "left": 488}, "words": "n3的患者应避免给予多西他赛。为了监测中性粒细胞减少的发生以免其发展至严"}, {"probability": {"variance": 0.00037, "average": 0.992646, "min": 0.89421}, "location": {"width": 562, "top": 767, "height": 31, "left": 221}, "words": "重程度导致感染,应对所有接受多西他赛治疗的患者进行频繁的血细胞计数"}, {"probability": {"variance": 0.005603, "average": 0.974007, "min": 0.596946}, "location": {"width": 850, "top": 796, "height": 33, "left": 223}, "words": "4.在接受了3天的地塞米松预治疗的患者,报道了严重过敏反应,表现为全身性皮疹/红斑,低血压和/或支气管痉挛"}, {"probability": {"variance": 0.003904, "average": 0.978067, "min": 0.607271}, "location": {"width": 851, "top": 828, "height": 34, "left": 224}, "words": "或非常罕见的致命性过敏症。一旦发生,应立即停药并给予适当的救治。既往有对多西他赛或其他含吐温-80制剂严"}, {"probability": {"variance": 0.000104, "average": 0.995091, "min": 0.962064}, "location": {"width": 207, "top": 868, "height": 24, "left": 224}, "words": "重过敏史的患者应避免使用"}, {"probability": {"variance": 0.011414, "average": 0.962476, "min": 0.377915}, "location": {"width": 826, "top": 890, "height": 35, "left": 255}, "words": "在接受了3天的地塞米松预治疗的患者中有6.5%(6/92)报道严重的体液留表现为以下一种或多种事件:不"}, {"probability": {"variance": 0.001178, "average": 0.987814, "min": 0.765777}, "location": {"width": 828, "top": 921, "height": 37, "left": 226}, "words": "能耐受的外周水肿,全身性红斑,心脏压塞,需要积极引流的胸腔积液,呼吸困难,明显的腹部膨胀(因为腹水"}, {"probability": {"variance": 2e-06, "average": 0.99849, "min": 0.99649}, "location": {"width": 90, "top": 1014, "height": 21, "left": 213}, "words": "【药品名称】"}, {"probability": {"variance": 0.023439, "average": 0.937602, "min": 0.445363}, "location": {"width": 203, "top": 1038, "height": 26, "left": 248}, "words": "通用名称:多西他赛注射液"}, {"probability": {"variance": 6.3e-05, "average": 0.993393, "min": 0.980144}, "location": {"width": 126, "top": 1068, "height": 23, "left": 241}, "words": "商品名称:艾素"}, {"probability": {"variance": 0.032247, "average": 0.925748, "min": 0.485884}, "location": {"width": 102, "top": 1096, "height": 22, "left": 242}, "words": "英文名称:De"}, {"probability": {"variance": 0, "average": 0.943969, "min": 0.943969}, "location": {"width": 26, "top": 1097, "height": 18, "left": 402}, "words": " Inje"}, {"probability": {"variance": 0.000535, "average": 0.980244, "min": 0.946963}, "location": {"width": 73, "top": 1124, "height": 22, "left": 242}, "words": "汉语拼音:"}, {"probability": {"variance": 2.7e-05, "average": 0.995799, "min": 0.988426}, "location": {"width": 86, "top": 1154, "height": 23, "left": 223}, "words": "成份】"}, {"probability": {"variance": 0.044513, "average": 0.788566, "min": 0.386017}, "location": {"width": 850, "top": 1167, "height": 39, "left": 248}, "words": "本品主要成份为多西他赛,其化学称为L2-(2.a(aS),11a..a-Ⅱ(1,-二基"}, {"probability": {"variance": 0.023527, "average": 0.863186, "min": 0.391162}, "location": {"width": 890, "top": 1196, "height": 37, "left": 209}, "words": "乙氧基)羰基]氨基}α-羰基苯丙酸[12b-乙酰氧-12-苯甲酰氧-2a34,4a.5.;10,11,1a12b-十二-4.,三羟基"}, {"probability": {"variance": 0.031825, "average": 0.843233, "min": 0.373596}, "location": {"width": 635, "top": 1227, "height": 33, "left": 212}, "words": "4a,8,13,13-四甲基-5-氧代-711亚甲基-1H-环五烯并34苯井[12b]氧杂丁环-9基]酯"}, {"probability": {"variance": 0.000324, "average": 0.987258, "min": 0.949078}, "location": {"width": 92, "top": 1264, "height": 20, "left": 244}, "words": "其结构式为:"}, {"probability": {"variance": 0, "average": 0.884925, "min": 0.884925}, "location": {"width": 28, "top": 1319, "height": 22, "left": 802}, "words": " OH"}, {"probability": {"variance": 0, "average": 0.151151, "min": 0.151151}, "location": {"width": 29, "top": 1358, "height": 29, "left": 645}, "words": " CH"}, {"probability": {"variance": 0.027047, "average": 0.779067, "min": 0.538637}, "location": {"width": 85, "top": 1341, "height": 31, "left": 700}, "words": "QH∥c"}, {"probability": {"variance": 0.031617, "average": 0.535773, "min": 0.357962}, "location": {"width": 23, "top": 1385, "height": 23, "left": 718}, "words": "C"}, {"probability": {"variance": 0, "average": 0.837629, "min": 0.837629}, "location": {"width": 17, "top": 1434, "height": 20, "left": 615}, "words": "0"}, {"probability": {"variance": 0.001469, "average": 0.980835, "min": 0.904173}, "location": {"width": 70, "top": 1474, "height": 28, "left": 442}, "words": " C(: )2"}, {"probability": {"variance": 0, "average": 0.899186, "min": 0.899186}, "location": {"width": 30, "top": 1465, "height": 22, "left": 559}, "words": " OH"}, {"probability": {"variance": 0.037162, "average": 0.679756, "min": 0.486981}, "location": {"width": 22, "top": 1491, "height": 22, "left": 828}, "words": "Ch"}, {"probability": {"variance": 0.052767, "average": 0.864622, "min": 0.389201}, "location": {"width": 140, "top": 1600, "height": 21, "left": 248}, "words": "分子式:CHNO"}], "language": 3}